Amicus Therapeutics, Inc. (FOLD) Social Stream
Amicus Therapeutics Inc (FOLD) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering FOLD.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 9 | $29 | $12 | $17.5 | $11.85 | 47.68% |
| 11 | $29 | $12 | $18.333 | $11.85 | 54.71% |
| 11 | $29 | $12 | $18 | $11.85 | 51.9% |
| 10 | $29 | $12 | $18.444 | $11.85 | 55.65% |
| 10 | $29 | $12 | $18.555 | $11.85 | 56.58% |
| 10 | $29 | $12 | $17.5 | $11.85 | 47.68% |
The Trend in the Analyst Price Target
FOLD's average price target has moved up $0.23 over the prior 18 months.
FOLD reports an average of 60.63% for its upside potential over the past 18 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-23 | 9 | 29 | 12.0 | 17.500 | 11.33 | 54.46% |
| 2021-11-23 | 10 | 29 | 12.0 | 17.500 | 11.33 | 54.46% |
| 2021-11-23 | 9 | 29 | 12.0 | 18.555 | 11.33 | 63.77% |
| 2021-11-23 | 10 | 29 | 12.0 | 18.555 | 11.33 | 63.77% |
| 2021-03-20 | 11 | 29 | 12.5 | 17.880 | 10.25 | 74.44% |
| 2020-05-28 | NA | 31 | 11.0 | 18.320 | NA | NA% |
FOLD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.44 | 7 | 0 | 2 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
FOLD's average broker recommendation rating improved by 0.67 over the prior 31 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- FOLD has a less variance in analysts' estimates than -455.01% of all US stocks.
- The number of analysts covering the stock of FOLD is higher than 500.83% of Pharmaceutical Products stocks.
- FOLD has a greater average analyst price target than 104.74% of stocks in the mid market cap category.
- FOLD has a greater upside potential (average analyst target price relative to current price) than 433.7% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Amicus Therapeutics Inc are IOVA, BCRX and IGMS.
What is the outlook for FOLD? Use POWR Ratings for clearer insight into price direction.